R. Beckman

Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker

R. Beckman, Z. Antonijevic, R. Kalamegham, 2016, Clinical pharmacology and therapeutics.

Abstract P4-16-09: Phase 1b/2 trial of the HER3 inhibitor patritumab (U3-1287) in combination with trastuzumab plus paclitaxel in newly-diagnosed patients with HER2+ metastatic breast cancer (MBC)

D. Campos, E. Cazap, R. Beckman, 2013 .

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms

HP Selker, MR Trusheim, AA Shrier, 2016, Clinical pharmacology and therapeutics.